These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 29347960

  • 1. Long-term outcome of definitive radiotherapy for cervical esophageal squamous cell carcinoma.
    Sakanaka K, Ishida Y, Fujii K, Itasaka S, Miyamoto S, Horimatsu T, Muto M, Mizowaki T.
    Radiat Oncol; 2018 Jan 18; 13(1):7. PubMed ID: 29347960
    [Abstract] [Full Text] [Related]

  • 2. Intensity-modulated radiotherapy for cervical esophageal squamous cell carcinoma without hypopharyngeal invasion: dose distribution and clinical outcome.
    Ishida Y, Sakanaka K, Fujii K, Itasaka S, Mizowaki T.
    J Radiat Res; 2019 Jul 01; 60(4):517-526. PubMed ID: 31083715
    [Abstract] [Full Text] [Related]

  • 3. Long-term clinical outcomes and prognosis after definitive radiotherapy for patients with cervical esophageal squamous cell carcinoma: a single-institution retrospective study.
    Zhang S, Sun J, Pan X, Kim JY, Zhu W, Zhou Y.
    J Thorac Dis; 2023 Dec 30; 15(12):6976-6987. PubMed ID: 38249918
    [Abstract] [Full Text] [Related]

  • 4. Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity.
    Haefner MF, Lang K, Verma V, Koerber SA, Uhlmann L, Debus J, Sterzing F.
    Radiat Oncol; 2017 Aug 15; 12(1):131. PubMed ID: 28810885
    [Abstract] [Full Text] [Related]

  • 5. Reduced toxicity with three-dimensional conformal radiotherapy or intensity-modulated radiotherapy compared with conventional two-dimensional radiotherapy for esophageal squamous cell carcinoma: a secondary analysis of data from four prospective clinical trials.
    Deng JY, Wang C, Shi XH, Jiang GL, Wang Y, Liu Y, Zhao KL.
    Dis Esophagus; 2016 Nov 15; 29(8):1121-1127. PubMed ID: 26663710
    [Abstract] [Full Text] [Related]

  • 6. Patterns of failure and clinical outcomes of definitive radiotherapy for cervical esophageal cancer.
    Zhao L, Zhou Y, Mu Y, Chai G, Xiao F, Tan L, Lin SH, Shi M.
    Oncotarget; 2017 Mar 28; 8(13):21852-21860. PubMed ID: 28423530
    [Abstract] [Full Text] [Related]

  • 7. Concurrent chemoradiotherapy for cervical esophageal squamous cell carcinoma: treatment results from a prospective observational study.
    Li HX, Liu J, Cheng Y, Liu MN, Fang WT, Lv CX.
    Dis Esophagus; 2018 May 01; 31(5):. PubMed ID: 29294022
    [Abstract] [Full Text] [Related]

  • 8. Additional radiotherapy following endoscopic submucosal dissection for T1a-MM/T1b-SM esophageal squamous cell carcinoma improves locoregional control.
    Hisano O, Nonoshita T, Hirata H, Sasaki T, Watanabe H, Wakiyama H, Ono M, Ohga S, Honda H.
    Radiat Oncol; 2018 Jan 29; 13(1):14. PubMed ID: 29378603
    [Abstract] [Full Text] [Related]

  • 9. Comparison of three-dimensional conformal radiation therapy, intensity-modulated radiation therapy, and volumetric-modulated arc therapy in the treatment of cervical esophageal carcinoma.
    Yang H, Feng C, Cai BN, Yang J, Liu HX, Ma L.
    Dis Esophagus; 2017 Feb 01; 30(2):1-8. PubMed ID: 27629865
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The efficacy and safety of simultaneous integrated boost intensity-modulated radiation therapy for esophageal squamous cell carcinoma in Chinese population: A single institution experience.
    Xu Y, Wang Z, Liu G, Zheng X, Wang Y, Feng W, Lai X, Zhou X, Li P, Ma H, Wang J, Hu X, Chen M.
    J Cancer Res Ther; 2016 Oct 01; 12(Supplement):82-88. PubMed ID: 27721262
    [Abstract] [Full Text] [Related]

  • 14. Patterns of failure after involved field radiotherapy for locally advanced esophageal squamous cell carcinoma.
    Li DJ, Li HW, He B, Wang GM, Cai HF, Duan SM, Liu JJ, Zhang YJ, Cui Z, Jiang H.
    J BUON; 2016 Oct 01; 21(5):1268-1273. PubMed ID: 27837632
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long-term results of concurrent chemoradiotherapy with daily-low-dose continuous infusion of 5-fluorouracil and cisplatin (LDFP) for Stage I-II esophageal carcinoma.
    Kumabe A, Fukada J, Kota R, Koike N, Shiraishi Y, Seki S, Yoshida K, Kitagawa Y, Shigematsu N.
    Dis Esophagus; 2018 Apr 01; 31(4):. PubMed ID: 29228166
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Prognostic analysis of definitive radiotherapy for early esophageal carcinoma(T1-2N0M0): a multi-center retrospective study of Jing-Jin-ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group].
    Lu N, Wang X, Li C, Wang L, Chen JQ, Zhang WC, Wang XM, Ge XL, Shen WB, Hu MM, Yuan QQ, Xu YG, Hao CL, Zhou ZG, Qie S, Xiao ZF, Zhu SC, Han C, Qiao XY, Pang QS, Wang P, Zhao YD, Sun XC, Zhang KX, Li L, Li GF, Liu ML, Wang YD.
    Zhonghua Zhong Liu Za Zhi; 2020 Feb 23; 42(2):139-144. PubMed ID: 32135649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.